Antag Therapeutics ApS: Financial statements 2025
CVR: 38402056
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Antag Therapeutics ApS (CVR 38402056) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -191,588,449 and a net result of DKK -200,999,582 compared with DKK -32,265,249 the year before. Equity in the 2025 report amounted to DKK 235,310. The solvency ratio was 0.8%. The company had 10 employees in the financial year.
- Gross Profit
- DKK -191,588,449
- Profit/Loss
- DKK -200,999,582
- Equity
- DKK 235,310
- Total Assets
- DKK 28,032,707
- Employees
- 10
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -191.6M | -201M | 235K | 10 |
| 2024 | - | -30.6M | -32.3M | 201.2M | 2 |
| 2023 | - | -13.7M | -13.8M | -9.2M | 2 |
| 2022 | - | -9.9M | -9.8M | 4.6M | 2 |
| 2021 | - | -13.1M | -14.9M | 10.9M | 6 |
Official annual report
How creditworthy is Antag Therapeutics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Antag Therapeutics ApS has published its annual report for 2024. Gross profit came to DKK -30,596,301, and the net result was DKK -32,265,249.
As of January 28, 2025, Jörg Möller has joined the board of directors of Antag Therapeutics ApS.
As of January 28, 2025, Alexander Hovard Sparre-Ulrich has left the board of directors of Antag Therapeutics ApS.
As of January 6, 2025, Jörg Möller is registered as adm. dir. of Antag Therapeutics ApS.
As of January 6, 2025, Alexander Hovard Sparre-Ulrich has stepped down as adm. dir. of Antag Therapeutics ApS.
About Antag Therapeutics ApS
Antag Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2017. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Antag Therapeutics IVS. The management consists of Philip Just Larsen. The board consists of Keith Richard Leonard Jr (chair), Alexander Volker Wilhelm Mayweg, Amit Kantilal Shah and Jørgen Søberg Petersen. The company's owners include Novo Holdings A/S, Dawn Holdco SCSp and Versant Venture Capital VII, L.P.. The company has 10 employees (2026). In 2025, the company reported a gross profit of DKK -191,588,449 and a net result of DKK -200,999,582 compared with DKK -32,265,249 the year before. Equity in the 2025 report amounted to DKK 235,310.